Edition:
United Kingdom

People: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

1,779.95INR
23 Aug 2019
Change (% chg)

Rs55.45 (+3.22%)
Prev Close
Rs1,724.50
Open
Rs1,720.00
Day's High
Rs1,790.00
Day's Low
Rs1,700.00
Volume
870,022
Avg. Vol
1,067,455
52-wk High
Rs3,307.95
52-wk Low
Rs1,652.35

Shah, Vijay 

Mr. Vijay Shah is Executive Director of Piramal Enterprises Limited. He is an Executive Director on the Board of Piramal Enterprises and the Director of Piramal Glass. Mr. Shah has been associated with the Piramal Group for 28 years. Over the Group’s history, he has successfully spearheaded many businesses and companies. Mr. Shah joined the Piramal Group in 1988. He initiated the Strategic Planning function in Piramal Enterprises. He took over as Managing Director of Gujarat Glass Limited in September, 1992. The Company became a dominant player in the Indian Pharma packaging market with 40% market share and commanded a premium pricing. With the success of building a business and turning around a loss-making company, Mr. Shah was put in charge of a completely diverse business of Pharmaceutical Formulations in India. He then took over as the Executive Director and Chief Operating Officer of Piramal Healthcare in 2000. During the period, the Company moved from rank 23 to rank 4 in Indian Pharma Industry with several acquisitions, and created the largest field-force in Indian pharmaceutical market with 3,500 people, spanning across 10 divisions and four businesses. He was involved in a number of acquisitions and handled post-acquisition integration, along with heading the healthcare vertical, which included Pharma Solutions and Critical Care businesses. In October 2005, Mr. Shah aided the acquisition of the loss-making Glass Group’s Cosmetic and Perfumery business in USA and then he once again took charge of Piramal Glass Limited as its Managing Director and successfully turned around a bankrupt company in the US acquisition, despite the recessionary trend. With effect from 1st January, 2012, Mr. Shah took charge as Executive Director & Chief Operating Officer of Piramal Enterprises Limited, in charge of Pharma Solutions and Critical Care. In January 2014, he was appointed as the Chairman of the Pharma Operations Board of Piramal Enterprises Limited.

Basic Compensation

Total Annual Compensation, INR 61,896,800
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 1,299,600
Fiscal Year Total, INR 63,196,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ajay Piramal

112,489,000

Swati Piramal

50,451,400

Vivek Valsaraj

14,642,000

Peter DeYoung

--

Jonathan Sandler

--

Vivek Sharma

--
As Of  31 Mar 2018